Aktis Oncology, Inc. (AKTS) Earnings
NASDAQ·Healthcare·Biotechnology
$22.64
-1.44%
Mkt Cap $1.32B
EPS — Estimate vs Actual
Mkt Cap
$1.32B
P/E
—
Fwd P/E
—
P/S
88.00
Rev TTM
—
EPS TTM
-$0.88
NASDAQ·Healthcare·Biotechnology
$22.64
-1.44%
Mkt Cap $1.32B
Mkt Cap
$1.32B
P/E
—
Fwd P/E
—
P/S
88.00
Rev TTM
—
EPS TTM
-$0.88